Lindsay, J., Freier, W., Jones, J., Basu, S., Al-Kaisi, F., Kishore, B., Gunawan, A., Neelakantan, P., Smith, D., Lakhwani, S. L., Pohlmann, A., Doerfel, S., Cheng, J., Loredo, A., Levin, R., Aydin, D., Karunanithi, K. (2026). Real-world effectiveness and safety of elranatamab in patients with relapsed/refractory multiple myeloma: Preliminary results from the prospective, non-interventional MagnetisMM-16 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19507